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Abstract. A retrospective analysis was performed on archival cervical smears from a group of 56 women with cervical
intraepithelial neoplasia (CIN), who had received follow-up by cytology only. Automated image cytometry of Feulgen-
stained DNA was used to determine the differences between progressive and regressive lesions. The first group of 30 smears
was from women who had developed cancer after initial smears with dysplastic changes (progressive group). The second
group of 26 smears with dysplastic changes had shown regression to normal (regressive group). The goal of the study was
to determine if differences in cytometric features existed between the progressive and regressive groups. CIN categories I,
II and III were represented in both groups, and measurements were pooled across diagnostic categories. Images of up to
700 intermediate cells were obtained from each slide, and cells were scanned exhaustively for the detection of diagnostic cells.
Discriminant function analysis was performed for both intermediate and diagnostic cells. The most significant differences
between the groups were found for diagnostic cells, with a cell classification accuracy of 82%. Intermediate cells could
be classified with 60% accuracy. Cytometric features which afforded the best discrimination were characteristic of the
chromatin organization in diagnostic cells (nuclear texture). Slide classification was performed by thresholding the number
of cells which exhibited progression associated changes (PAC) in chromatin configuration, with an accuracy of 93 and 73%
for diagnostic and intermediate cells, respectively. These results indicate that regardless of the extent of nuclear atypia
as reflected in the CIN category, features of chromatin organization can potentially be used to predict the malignant or
progressive potential of CIN lesions.
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1. Introduction
Since the introduction of cytological diagnosis of cervical (pre-)malignant lesions, the surface of the
uterine cervix has become one of the most extensively examined areas of the human body. Dysplastic
cellular changes can be identified in cytological smears, and thus selected women can be treated in
an early phase before further signs or symptoms have occurred. Organized screening has significantly
contributed to the reduction, incidence, and mortality from cervical cancer [1,16,24,25,27,28]. This
success, however, has come at the cost of treating too many women. Most women who are treated for
dysplasia would never have developed cancer, because the lesions would have regressed spontaneously
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to normal [16]. The problem of over-treatment continues to worsen. The management of the atypical
squamous cells (ASCUS category of the Bethesda classification system, Papanicolaou class 2) has
become increasingly aggressive [12,14,31]. This approach is likely to very ineffective and expensive,
and to create much anxiety among women.
Data from the screening program in the Netherlands illustrate the discrepancy between the number
of positive smears and the incidence of cervical cancer (Table 1). In the Netherlands each year
about 400,000 women are being screened after invitation by the screening organizations, out of a
population of 3,200,000 women at risk between the age of 30 and 60 years [32]. An estimated
12,500 women will have “positive” follow-ups and are candidate to be treated [13]. The calculated
incidence of invasive cervical cancer is, however, much lower, e.g., 120–200 per 400,000 women
in this age group [29]. From these data it is obvious that routine cytomorphologic classification of
smears does not have the power to recognize only those patients who have a high probability to
develop cancer.
In a previous image analysis study we have analyzed diagnostic cells within Feulgen-stained smears
of patients who, after initial smears showing dysplasia, had developed cancer. We indicated that
image analysis may be helpful to discriminate between progressive and non-progressive intra-epithelial
changes of the cervix [11]. Furthermore, image analysis of Malignancy Associated Changes (MAC’s)
as present in normal appearing intermediate cell has been shown to be of value to identify co-occurent
dysplastic changes [23].
In the present study of archival material we performed image cytometric analysis of diagnostic and
intermediate cells as present within 56 Feulgen-stained smears. The first group of 30 smears was
from women who had developed cancer after initial smears with dysplastic changes. The second
group of 26 smears with dysplastic changes had shown regression to normal. Since these women
did not receive treatment (until the development of invasive carcinoma in the progressive group), the
lesions in this study group are representative of the natural history of CIN. The aim of this study
was to determine whether image cytometric analysis could help to discriminate between these two
groups of progressive and regressive lesions, and to test whether DNA-cytometric features could help
to correctly classify such lesions as being progressive or regressive.
Table 1
Cervical screening in the Netherlands
Cases per year Description of population
Number of screened women
3,200,000 Women at risk between 30 and 60 years of age
380,000–450,000 Number of women screened per year (60–70% attendance; 5-year interval)
±50,000 “Non-negative” smears by initial cytology (12% of smears are initially called
“non-negative” and followed up)
±12,500 Cases are “positive”, either in initial smear, or on follow-up (assumes 25%
of “non-negative” smears have “positive” follow-up; women are referred to
gynecologists)
Calculated number of women with invasive cancer of the cervix
960–1,600 Calculated number of cases of invasive cancer per 3,200,000 (assumes 30–
50 cases of cancer per 100,000 women between 30 and 60 years in unscreened
population)
120–200 Calculated incidence of cases of cancer per 400,000 women
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2. Material and methods
2.1. Patient group
From the archives of the department of cytopathology of the British Columbia Cancer Agency
(BCCA), two groups of smears were selected (Table 2). The first group contained 30 smears of
successive patients who, after previous cervical smears consistent with CIN I, II or III, had developed
an invasive squamous cell carcinoma of the cervix that was histologically diagnosed in 1988. The
mean time interval between the cytologic diagnosis of CIN and histologic diagnosis of cancer was
24 months (range: 1–89 months). The CIN lesions of these patients (13 cases of CIN I, 9 cases of
CIN II, 8 cases of CIN III) are labeled with the prefix “pro” for their progressive course. The mean
age of the patients at diagnosis of a pro-CIN lesion was 42.0 years (range: 24–86 years).
The second group contained 26 smears of women, who had been followed by cytology only. The
mean time interval between the cytologic diagnosis of CIN and two successive normal smears was
87 months (range: 43–128 months). The CIN lesions of these patients (two cases of CIN I, 14 cases
of CIN II, 11 cases of CIN III) are labeled with the prefix “reg” for their regressive course. The mean
age of the patients with a reg-CIN lesion was 33 years (range: 19–66 years).
2.2. Cytologic material
Cytologic smears had been routinely prepared by scraping the surface of the cervical mucosa
with a wooden spatula. The material was then put on slides, air dried, and stained according to the
Papanicolaou technique for routine diagnostic purposes. The initial cytologic diagnosis was accepted as
the reference diagnosis. All slides that were accepted for this study were reviewed by a cytopathologist.
For cytometric analysis the coverslips of the slides were removed using xylol and the specimens were
then rehydrated according to the following sequence, ethanol 96% (twice), ethanol 70%, ethanol 40%
and distilled water. Thereafter specimens were de-stained in a mixture of methanol, 37% formaldehyde
and acetic acid (85 : 10 : 5 by volume) for one hour, rehydrated, treated with acid hydrolysis (5 N HCI)
at 22◦C for 60 min and re-stained using the (Thionin-SO2) Feulgen procedure. No cytoplasmic
counterstain was used.
2.3. Image acquisition
Image acquisition was performed using the Oncometrics Cyto-SavantTM automated quantitative
image cytometer (Oncometrics Imaging Corp., Vancouver, BC, Canada). This includes a 12 bit Micro
Table 2
The total number of smears and of intermediate and diagnostic cells selected for each of the
diagnostic subgroups
Diagnostic subgroup N smears Intermediate cells Diagnostic cells
pro-CIN I 13 4168 590
pro-CIN II 9 2751 493
pro-CIN III 8 983 788
Subtotal 30 7902 1,871
reg-CIN I 2 174 16
reg-CIN II 13 2336 565
reg-CIN III 11 1318 1,010
Subtotal 26 3828 1,591
Total 56 11,730 3,462
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Imager 1400 digital camera (picture elements 6.8 µm × 6.8 µm), an automated pneumatic slide loader,
and a motorized xyz-stage. Thionin-Feulgen-stained nuclei were measured with monochromatic light
at a wavelength of 600 nm (band width 10 nm), using a 20× 0.75 N.A. PlanApo objective lens. The
effective pixel size was 0.34 µm × 0.34 µm. Nuclei were automatically located in the digital images
using a grey level thresholding procedure to locate all objects, followed by a refined individual cell
focusing algorithm. Finally, the segmentation of the object was standardized using an edge relocation
algorithm to precisely place the edge of the object at the region of highest local grey level gradient [17].
2.4. Cell selection
Using a subset of the 126 nuclear features measured with the cytometer, a cell classification function
was applied to the data as the scan proceeded, and 4 classes of objects were distinguished: (1) interme-
diate cells, (2) diagnostic cells, (3) lymphocytes, and (4) debris. The slides were scanned exhaustively
to detect all diagnostic cells and until a specified number of lymphocytes and intermediate cells were
obtained. Images of all epithelial cells were re-classified by a cytotechnologist in order to refine the
machine classification.
2.5. Image analysis
Nuclear features were extracted from the digitized nuclear images of each selected cell. The 126 fea-
tures were calculated using the procedure incorporated within the Oncometrics Cyto-SavantTM image
cytometer [9]. These features can be classified into six different feature groups: (1) morphometric –
describing the size and shape of the nucleus; (2) photometric – describing the distribution of optical
density within the stained nucleus, including the integrated optical density (IOD, proportional to the
DNA content); (3) discrete texture – relying on the division of nucleus into regions of high, medium,
and low chromatin condensation states, and describing the spatial distribution and photometric prop-
erties of these regions; (4) Markovian texture – features which characterize the distribution of grey
level intensity values between adjacent pixels in the image; (5) run-length texture – features which
describe the length of contiguous regions with constant grey level intensity, as well as the photometric
properties of these regions; and (6) fractal texture, which measure the surface area of the 3D plot of
optical intensity vs. x-y position of the pixels in the nuclear image.
2.6. Statistical analysis
For the statistical analyses of the intermediate cells all 56 smears (30 smears with pro-CIN and
26 smears with reg-CIN) were accepted. For the analysis of the diagnostic cells, 46 smears were
accepted in which 15 or more diagnostic cells had been detected (26 pro-CIN; 20 reg-CIN). Because
of the relatively small number of cases within each of the progressive and regressive subgroups, all
pro-CIN I, II and III lesions were pooled to form one group (pro-CIN) for the analysis, as were all reg-
CIN I, II and III lesions (reg-CIN group). A stepwise linear discriminant analysis was used to select
those DNA-cytometric features that could discriminate between individual cells of the pro-CIN and
reg-CIN lesions (using multivariate statistics F-to-Enter and F-to-Remove). Two separate discriminant
analyses were performed using feature values of (1) diagnostic cells, and (2) intermediate cells. For
each group of cells the discriminant analysis was performed with selection of a subset of features from
the 126 Oncometrics parameters. The resulting discriminant functions were used to classify each of
the cells on the slide as positive or negative for progression associated changes (PAC). The slides were
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then classified by setting a threshold on the percentage of PAC-positive cells detected. This threshold
was selected to maximize the slide classification accuracy as “progressive” or “regressive”. An
alternative method for slide classification was also investigated. For each slide, means and variances
of the feature measurements were calculated, and these parameters were used as input to stepwise
discriminant function analysis for slide classification.
2.7. DNA histograms
The DNA content of nuclei, expressed as DNA index, is defined as the normalized measure of
integrated optical density of a nucleus. Normalization was performed using internal controls cells,
by dividing the DNA content of the nucleus by the median value of the DNA content of leukocytes,
present on each slide. The staining intensity over this series of archival slides varied considerably: the
median values of integrated optical densities (MD IOD) of the internal control cells ranged from 58 to
147 (mean: 105, 95% confidence interval: 100–110). The mean value of the coefficient of variation
of the controls was 16.7%, which exceeds the recommendations of the ESCAP consensus conference
on cytometry of DNA content [5]. This large CV is due to the archival nature of the specimens
available for analysis, and indicates that the sensitivity of ploidy determinations is compromised in
this series. DNA histograms were displayed using a bin-size of 0.05. Two types of DNA histograms
were compiled: (1) DNA histograms of all diagnostic cells per slide of all cases with 15 or more
diagnostic cells; and (2) DNA histograms of diagnostic cells combined from different slides within
diagnostic (sub)groups: e.g., pro-CIN I, pro-CIN II, etc., and all cells combined from pro-CIN lesions
and reg-CIN lesions. The DNA ploidy patterns of each case was visually classified as DNA-diploid,
DNA-polyploid, or DNA-aneuploid, according to definitions as described previously [11].
The DNA index (DI) is defined as the DNA content of the cell divided by the mean DNA content
of the internal diploid control cells, so that a DI of 1.0 corresponds to a diploid cell. DI values greater
than 1.25 are taken to be aneuploid.
The 2.5c and 5c exceeding rates (ER) were defined as the percentages of diagnostic cell nuclei per
specimen, with DI values of DI > 1.25 and DI > 2.5, respectively. The mean and CV of the DNA
index over the diagnostic cells were also determined. The entropy of the DNA histogram, representing





where pi is the proportion of cells within histogram bin i, and where the sum
∑
i is taken over all
bins in the histogram. All DNA histograms were compiled using 100 bins over an interval of DI from
0.0 to 5.0.
3. Results
3.1. Classification of diagnostic cells
The results of the stepwise linear discriminant analysis of the diagnostic cells to discriminate between
pro-CIN and reg-CIN lesions are shown in Table 3. A number of morphometric features showed
significant differences between cells from pro-CIN and reg-CIN lesions, the most discriminating of
which are listed below:
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Table 3
Classification matrix for diagnostic cells. Performance of dis-
criminant function derived from diagnostic cells from pro-CIN
and reg-CIN lesions
Group % Correct Number of cells classified
into group
Progressive Regressive
Progressive 89 1665 206
Regressive 73 430 1161
Total 82 2095 1367
– OD max: the largest value of the optical density of the object, normalized against the slide mean
of the iod (iod-norm);
– Mean radius: the mean value of the distance from the centroid of the object to the object edge;
– Med DNA amnt: a discrete texture feature representing the total DNA content of regions of
medium-condensed chromatin;
– Range extreme: the difference between the largest local maximum and the smallest local minimum
of optical intensity within the nucleus, normalized against (iod-norm);
– Center of gravity: represents the distance from the geometrical center of the object to the “center
of the mass” of the optical density function, normalized by the mean radius of the object. Large
values of this feature indicate asymmetry of the optical density distribution over the nucleus;
– Fractal area 1: this feature is derived through analysis of the 3D plot of the optical intensity vs.
the x and y spatial coordinates of the cell image. The fractal area is the surface area of this
plot, and represents the complexity of the optical density distribution (e.g., a cell with completely
smooth OD distribution will have a smaller fractal area than a cell with alternating patches of
light and dark chromatin). Fractal area 1 is the surface area at full image resolution;
– Run length 90: this run length texture feature is a measure of the number of consecutive pixels
in the image with constant grey level, giving another estimate of the uniformity of optical density
distribution in the nucleus. In this case, the runs of constant grey level are computed in the
vertical direction, denoted by the 90 in the feature title.
Using the diagnostic cells of the pro-CIN and reg-CIN lesions a discriminant function was derived
based on three selected features (mean radius, med DNA amount, range extreme), with overall clas-
sification accuracy between progressive and regressive lesions of 82%. The resulting classification
matrix is shown in Table 3. Using a jackknife procedure, the cells of pro-CIN lesions were classified
correctly in 89% of cases, the cells of the reg-CIN lesions in 73% of cases. The performance of the
discriminant function without the jackknife procedure was virtually equivalent.
Figure 1 shows a plot of the discriminant function derived from diagnostic cells from the pro-CIN
and reg-CIN lesions. The selected features exhibit a high heterogeneity in the regressive lesions,
showing three distinct peaks, whereas the plot of the progressive lesions is essentially unimodal.
The stability of all discriminant analyses was evaluated by splitting the sample in half and by
using the discriminant function derived from one half to classify the other half (and vice versa). The
features used in these analyses were forced to be identical to those which comprised the original
discriminant function. For the CIN lesions analyzed in this manner, the jackknifed classification
accuracies were 80.4 and 79.8% for the two halves of the data, confirming that the features provide
a stable discrimination between the progressive and regressive groups.
Classification of slides was performed using two different methods. In the first, discriminant analysis
was performed using the mean and variance of feature measurements over individual slides. With this
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Fig. 1. Discriminant score derived from diagnostic cells from pro-CIN and reg-CIN lesions.
method, the dimensionality of the feature space is restricted by the small number of cases. Allowing
two of the most discriminating variables to be entered into the discriminant function, a classification
accuracy of 75% is achieved for diagnostic cells. The jackknifed classification accuracy using these
two variables is 69%, suggesting that this analysis is not stable due to the small sample size.
Analysis of the feature means and variances may tend to obscure the existence of subpopulations of
cells which may be more likely to establish a progressive clone. More insight into the distribution of
feature measurements can be gained if we analyse the behavior of the cell discriminant function over
the population of cells within individual slides. In this case classification of each slide is performed
by thresholding the percent of cells positive for progressive associated changes on each slide (PAC,
defined as a cell with discriminant score >0). The classification accuracy, using diagnostic cells from
46 slides, was 93% at a threshold of 80% PAC+ cells. For pro-CIN (N = 26) the classification
accuracy was 96%. For reg-CIN (N = 20) the classification accuracy was 90%.
Figure 2 shows typical examples of diagnostic cells of, respectively, PAC+ nuclei from pro-CIN
lesions and PAC− nuclei from reg-CIN lesions.
3.2. Classification of intermediate cells
The results of the stepwise linear discriminant analysis of the intermediate cells to discriminate
between pro-CIN and reg-CIN lesions are shown in Table 4. The following set of features were
shown to exhibit the most significant differences:
– Mean radius;
– DNA index;
– Low DNA area: a discrete texture feature representing the ratio of the area of the low optical
density regions of the object to the total object area. Analogous definitions exist for medium and
high density DNA areas;
– Medium average distance: this feature represents the asymmetry of the distribution of medium
density chromatic, and measures the average distance of pixels representing medium density
chromatin from the geometric centre of the object;
– High density objects: the number of distinct particles of high density chromatin;
– Contrast: a Markovian feature which emphasizes the contrast between adjacent pixel intensities.
This feature is highest for objects with large variations between adjacent pixels;
– Range extreme (see above).
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(a)
(b)
Fig. 2. Images of digitized nuclei of Feulgen-stained diagnostic cells of (a) pro-CIN and (b) reg-CIN lesions.
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Table 4
Classification matrix for intermediate cells. Performance of dis-
criminant function derived from intermediate cells from pro-CIN
and reg-CIN lesions
Group % Correct Number of cells classified
into group
Progressive Regressive
Progressive 60.8 4803 3099
Regressive 58.9 1574 2254
Total 60.1 6509 5221
Fig. 3. Discriminant score derived from intermediate cells from pro-CIN and reg-CIN lesions.
Using the intermediate cells of the pro-CIN and reg-CIN lesions a discriminant function was derived
allowing 4 of the most discriminating variables to be entered (medium average distance, high density
objects, contrast, and range extreme). The overall cell classification accuracy between progressive
and regressive lesions was 60%, considerably lower than that for diagnostic cells. The resulting
classification matrix is shown in Table 4. Using a jackknife procedure, the intermediate cells of
pro-CIN lesions were classified correctly in 61% of cases, the cells of the reg-CIN lesions in 59% of
cases. Stability of discriminant analysis was again confirmed by dividing the sample in half.
Figure 3 shows a plot of the discriminant function derived from intermediate cells from the pro-CIN
and reg-CIN lesions. In contrast to the diagnostic cell analysis, the overlap between the two groups is
considerable, and both plots show an essentially unimodal distribution. Also in contrast to the analysis
of diagnostic cells, the variability in the discriminant score for regressive lesions is comparable to that
for the progressive.
Slide classification was again performed by thresholding the percent of PAC+ cells on each slide.
The classification accuracy, using intermediate cells, was 73% at a threshold of 40% PAC+ cells. For
pro-CIN the classification accuracy was 70%. For reg-CIN the classification accuracy was 76%.
The accuracy was similar when slide classification was performed using feature means and variances
as input variables to discriminant function analysis. With feature selection for the set of two most
discriminating variables, the accuracy was 70% for both jackknifed and non-jackknifed classifications.
Figure 4 shows typical examples of intermediate cells from pro-CIN and reg-CIN lesions, respec-
tively.
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(a)
(b)
Fig. 4. Images of digitized nuclei of Feulgen-stained intermediate cells of (a) pro-CIN and (b) reg-CIN lesions.
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3.3. DNA histograms
The plots of DNA index of all diagnostic cells from the (sub-)groups of progressive and regressive
CIN lesions are shown in Fig. 5. The DNA index is the normalized value of the DNA content (IOD).
There is little difference between reg-CIN and pro-CIN lesions. Reg-CIN lesions do show more
heterogeneity. The results of DNA ploidy analysis in each of the smears from 26 progressive and
20 regressive CIN lesions with 15 or more diagnostic cells per specimen, are shown in Table 5. In the
pro-CIN lesions DNA-diploidy did not occur. Eight (31%) pro-CIN lesions were classified as DNA-
polyploid and 18 (69%) as DNA-aneuploid. DNA-diploidy was found in three (15%) reg-CIN lesions.
Four (20%) reg-CIN lesions were classified as DNA-polyploid and 13 (65%) as DNA-aneuploid.
The mean and standard deviation of the histogram statistics over slides from the various diagnostic
categories are presented in Table 5 for the following features of the DNA histograms: the 2.5c and
5c exceeding rates, mean DNA index, CV of DNA index, and entropy. None of the features shown
exhibited a significant difference (p > 0.1) between pro-CIN and reg-CIN lesions, although their
distributions were notably different. Cells exceeding 5c in DNA index are relatively rare in these
lesions. The mean DNA index and 2.5c exceeding rate are higher in the progressive lesions, and
tend to increase with CIN grade in both categories. The CV of the DNA index is higher within the
regressive lesions, particularly in the regressive CIN III category.
4. Discussion
The most direct explanation for the significance of DNA-cytometric analysis in cervical dysplasia
is afforded by observations that chromosomal aneuploidy, and the DNA-cytometric equivalent “DNA
aneuploidy”, may be regarded as a marker for neoplastic transformation [4]. It has been shown that the
DNA profile of Feulgen-stained smears of the uterine cervix have significant prognostic information [2,
3,23,26]. A recent study of the DNA-cytometric feature N5C (the absolute number of cells with DNA
content of more than 5c) of patients with cervical neoplasia showed that the N5C values significantly
increased with increasing severity of CIN grade. However, the N5C values could not discriminate
between the two groups: (1) CIN II or more, and (2) CIN I or less [30]. These findings are in
Table 5
DNA histogram statistics for cases with 15 or more diagnostic cells
Feature Statistic Progressive lesions Regressive lesions
CIN 1 CIN 2 CIN 3 Total CIN 1 CIN 2 CIN 3 Total
2.5c exceeding mean 0.80 0.82 0.83 0.82 0.69 0.65 0.77 0.71
SD 0.27 0.20 0.19 0.22 – 0.36 0.30 0.32
5c exceeding mean 0.04 0.02 0.06 0.04 0.00 0.06 0.11 0.08
SD 0.04 0.04 0.12 0.07 – 0.07 0.21 0.03
Mean DNA index mean 1.73 1.70 1.76 1.73 1.42 1.66 1.78 1.70
SD 0.28 0.22 0.36 0.28 – 0.33 0.53 0.42
CV DNA index mean 22 21 21 21 26 23 53 37
SD 7.50 5.30 5.60 6.70 – 8.20 88 60
Entropy mean 0.56 0.57 0.62 0.58 0.47 0.53 0.58 0.55
SD 0.08 0.06 0.08 0.08 – 0.10 0.14 0.12
Diploidy count 0 0 0 0 0 1 2 3
Polyploidy count 4 2 2 8 0 4 0 4
Aneuploidy count 7 5 6 18 1 5 7 13
Cases total 11 7 8 26 1 10 9 20





Fig. 5. Histograms of the DNA index of diagnostic cells from pro-CIN and reg-CIN lesions. The inset represents an
expanded view of the region between DNA index 2.5 and 5. (a) CIN I progressive; (b) CIN II progressive; (c) CIN III
progressive; (d) CIN I and II regressive; (e) CIN III regressive; (f) Progressive lesions combined from CIN I, II and III;
(g) Regressive lesions combined from CIN I, II and III.
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Table 6
Descriptive statistics for selected features of diagnostic cells
Feature Progressive Regressive
Mean values
61 DNA index 1.70 1.76
10 mean radius∗ 15.50 14.90
63 OD max 0.426 0.517
66 low DNA amnt 0.244 0.225
67 med DNA amnt∗ 0.534 0.394
68 high DNA amnt 0.222 0.381
96 range extreme∗ 235 422
98 centre of gravity 0.039 0.038
103 fractal area 1 9850 7340
121 run length 90 205 202
Counts 1871 1592
Coefficients of variation
61 DNA index 0.295 0.335
10 mean radius∗ 0.191 0.222
63 OD max 0.334 0.437
66 low DNA amnt 1.050 1.314
67 med DNA amnt∗ 0.460 0.647
66 high DNA amnt 1.245 0.929
96 range extreme∗ 0.395 0.432
98 centre of gravity 0.640 0.605
103 fractal area 1 0.367 0.445
121 run length 90 0.350 0.384
Features included in stepwise linear discriminant analysis are in-
dicated with an asterick. Other features are listed for reference.
agreement with our previous results which showed that the 2.5c exceeding rate (ER) increased with
increasing severity of the lesion [12]. In that study no relation could be found between the 2.5c ER
and the progressive or regressive behavior of the CIN lesion. In the same study it was indicated
that measurement of nuclear shape and chromatin texture features have the potential to provide a
more sensitive indicator of progressive potential, as has been demonstrated in adenoma–carcinoma
progression in colon [18].
With reference to the feature means in Table 6, it is possible to propose a translation of the diagnostic
cell classifications into visually apparent light microscopical cytologic characteristics. It can be said
that, on average, PAC+ diagnostic cells are larger, with a significantly higher amount of DNA in
regions of medium-condensed chromatin. There is an increase in the average run lengths detected
in these cells, possibly due to the increases in the size of contiguous regions of medium condensed
chromatin. The contrast of these cells is not as great as in PAC− cells, as reflected in both the OD max
and range extreme parameters. The fractal area parameter indicates that the chromatin distribution is
condensed in a more disorganized manner in PAC+ cells, occupying significantly more surface area
in the 3D plot of OD vs. x-y position.
For most variables the diagnostic cells from regressive lesions exhibit a marked increase in CV
compared to measurements from the progressive cases, a heterogeneity which is also reflected in the
histogram statistics in Table 5. In particular, the CIN III regressive lesions show a pronounced increase
in CV of DNA index, as well as a quite large variation in this parameter from slide to slide. The 5c
exceeding rate, mean DNA index, and entropy all show similar behavior for CIN III regressors. The
reasons for this heterogeneity are not clear; these regressive lesions are evidently more advanced in
their karyotypic evolution and yet have not developed the capacity to invade. A number of biological
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Table 7
Descriptive statistics for feature measurements of intermediate cells
Variable Progressive Regressive
Mean values
61 DNA index 0.988 0.991
16 mean radius 12.8 13.0
28 contrast 20.9 21.2
67 low DNA area 0.404 0.443
69 high DNA area 0.040 0.031
78 med av distance 0.594 0.587
86 high density objects 0.836 0.913
96 range extreme 221 241
Counts 7902 3828
Coefficients of variation
61 DNA index 0.133 0.180
16 mean radius 0.101 0.101
28 contrast 0.274 0.258
67 low DNA area 0.485 0.459
69 high DNA area 1.720 1.171
78 med av distance 0.122 0.108
10 high density objects 1.160 1.120
96 range extreme 0.247 0.203
mechanisms may be invoked to explain this behavior, but it may also be true that CIN III regressors
– representing the most extreme discordance between diagnosis and prognosis – do not constitute a
consistent diagnostic category.
The analysis of intermediate cells proceeded in an analogous manner but yielded less resolution on
a cell by cell basis in the differences between regressive and progressive lesions. Only a slight shift
is evident between the main peaks in the plot of discriminant score in Fig. 3. For this reason it is
more difficult to propose a translation of the discriminating cytometric variables to visually apparent
cytologic features. The differences between progressive and regressive lesions are represented by
shifts in the value of feature measurements over a large population of cells, and the overlap between
the groups are quite large. It may be more reasonable to consider these differences as sub-visual,
although with reference to Table 7 it might be said that intermediate cells from regressive lesions tend
to be larger, with less extensive regions of high and medium-condensed chromatin. The range of the
extreme parameter indicates that the contrast of the smaller highly condensed chromatin regions is
greater in cells from regressive lesions. The Markovian parameters also indicate that the chromatin
pattern is more irregular in cells from regressive lesions. All of these parameters are consistent with
a more finely granular appearance of PAC− intermediate cells, which may be suggestive of some
form of “reactive atypia”. Although this cytologic category is not well understood, it is possible to
speculate that this may be an important mechanistic aspect of CIN regression.
Slide classifications were obtained by applying a threshold to the number of PAC+ cells present
on the slide. For diagnostic cells, optimal accuracy (93%) is obtained if we concede that regressive
lesions can have as many as 80% of diagnostic cells which are positive for PAC. Similarly, optimal
accuracy (73%) is achieved for intermediate cells at the level where 40% of intermediate cells in
regressive lesions exhibit PAC+ features. These cutoff points are arbitrarily selected to afford the best
classification accuracy, and should not be interpreted as the literal “burden” of PAC+ cells. Rather
these results indicate that there are large differences in feature distributions between reg-CIN and
pro-CIN lesions, even though there is considerable overlap between these categories.
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It is not straightforward to determine confidence limits for the use of thresholds to classify slides. It
is a well-recognized problem in statistics that such procedures may tend to bias the results in favor of
a more optimistic classification accuracy. It is important to emphasize that the statistical significance
of this study is limited by the small number of cases, and that we do not propose at this point to
have developed a classification scheme suitable for use in the setting of a screening program. A much
larger, independent sample would be necessary in order to confirm these results. At a minimum this
study does demonstrate that features of chromatin organization exhibit significant differences between
progressive and regressive lesions. These differences are most convincingly evident in the diagnostic
cells. If confirmed on a larger series of specimens these results may have significant implications for
the management of CIN.
In the present study of 56 women with CIN we have shown that a discrimination between a progres-
sive or regressive course of the disease is possible with 93% accuracy (slide classification). 96% of
the diagnostic cells from pro-CIN lesions were correctly classified, and 100% of slides from pro-CIN
slides were correctly classified using a threshold of 80% PAC+ cells. The present findings are based
on DNA measurements of just one Feulgen-stained specimen. It is possible that classifiers based on
changes in cytometric features in two or more subsequent smears can further improve the sensitiv-
ity and specificity of the test. This hypothesis has been dictated by acquired knowledge regarding
the existence of sequential cellular changes during the evolution of neoplasia, discriminating several
phases of malignant transformation: (1) initiation, genetic instability, (2) focal aberrant proliferation,
(3) focal dysplastic proliferation, (4) microinvasive growth, and (5) metastasis [6].
Based primarily on the analysis of colorectal and breast carcinoma, it has been proposed that
in the majority (70%) of epithelial tumors, genetic instability is driven by what has been termed a
“monosomic” pathway of chromosomal evolution [9,19,20]. This is characterized by a high frequency
of chromosomal rearrangements, deletions of chromosome arms (less frequent duplication), and mitotic
missegregation. The predominant karyotype is initially hypodiploid, but these cells possess a strong
tendency towards endoreplication to hypotetraploidy, and subsequent development of “pseudotriploid”
subclones with variable loss of duplicated chromosomes. Another subset of tumors (20–25%) has been
characterized as “trisomic”. Chromosomal rearrangements and deletions are more infrequent, and the
most common abnormality is the duplication of entire chromosomes. There is relatively little tendency
towards endoreplication and the development of polyploid side lines. A third category, comprising
5–7% of epithelial tumors, is characterized by only normal karyotypes, and has been linked to defects
in replication error repair.
In cervical carcinoma karyotypic evaluations are scarce, but interphase cytogenetics using cen-
tromere enumeration probes has revealed aneusomies for a variety of chromosomes. In a recent study
we have shown polyploidization of all investigated chromosomes occurs in progressive/persistent CIN
lesions [7]. Furthermore, we have shown that progression from low grade towards high grade CIN
lesions was accompanied by progressive increases in chromosome index (CI) for chromosomes 1, 7
and X, while for chromosomes 3, 6, 8, 11 and 17 no such correlation was found. Further progres-
sion towards invasive carcinoma of the cervix seems to be accompanied by specific chromosomal
rearrangements.
According to a recently published CGH article [15], gain and amplification of sequences at 3q is
associated with progression to invasive carcinoma in 90% of cases examined. Although it seems clear
that this progressive genomic instability is correlated with classic changes in chromatin appearance in
intra-epithelial neoplasia, there is little direct evidence for an impact of chromosomal rearrangements
on the organization of chromatin in the interphase nucleus. A number of plausible mechanisms have
been proposed but this remains a matter of speculation.
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The most intriguing aspect of this study is that common differences in the chromatin patterns of
progressive lesions are measurable in samples pooled from all diagnostic categories of CIN. This
would seem to indicate that chromatin patterns exhibit an underlying indicator of progressive potential
which is independent of the extent or severity of nuclear atypia. The potential for progression may
not then be driven by the same processes which may underlie a putative progression of CIN through
increasingly severe stages of CIN I, II and III.
It is also possible that this study merely underscores the shortcomings of the visual assessment of
cytopathologic features of CIN. The discordance between diagnosis and prognosis, most extreme in
the case of regressive CIN III lesions, may be due to the fact that the appropriate cues may be difficult
if not impossible to evaluate in a subjective manner. In this respect it is likely that standardized
measurement of chromatin configuration parameters will ultimately provide a more consistent basis
for the assignment of risk to these lesions.
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